Blood mRNA Biomarkers for Detection of Treatment Response in Acute Pulmonary Exacerbations of Cystic Fibrosis

Thorax - United Kingdom
doi 10.1136/thoraxjnl-2012-202278
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Identification of Novel Blood Biomarkers of Treatment Response in Cystic Fibrosis Pulmonary Exacerbations by Label-Free Quantitative Proteomics

Scientific Reports
Multidisciplinary
2019English

Characterization of Inpatient Cystic Fibrosis Pulmonary Exacerbations

Pediatrics
Child HealthPediatricsPerinatology
2017English

Treatment of Pulmonary Exacerbations of Cystic Fibrosis Leads to Improved Antioxidant Status

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1999English

Inhaled Hypertonic Saline Reduces Pulmonary Exacerbations in Cystic Fibrosis

Thorax
PulmonaryRespiratory Medicine
2006English

Glucose Tolerance During Pulmonary Exacerbations in Children With Cystic Fibrosis

PLoS ONE
Multidisciplinary
2012English

Effects of Puberty on Cystic Fibrosis Related Pulmonary Exacerbations in Women Versus Men

Pediatric Pulmonology
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2013English

Procalcitonin-Guided Antibiotic Use in Acute Exacerbations of Idiopathic Pulmonary Fibrosis

International Journal of Medical Sciences
Medicine
2013English

Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis

Frontiers in Pharmacology
Pharmacology
2019English

Idiopathic Pulmonary Fibrosis Acute Exacerbations: Where Are We Now?

Expert Review of Respiratory Medicine
ImmunologyPublic HealthAllergyEnvironmentalPulmonaryRespiratory MedicineOccupational Health
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy